A Health Economic Trial in Adult Patients Undergoing Open Colectomy MA402S23B302

PHASE4TerminatedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

July 31, 2012

Study Completion Date

July 31, 2012

Conditions
Bowel Obstruction
Interventions
DRUG

IV morphine sulfate

Patients in this group will receive IV morphine sulfate via patient-controlled analgesia (PCA) pump, as needed. The PCA pump will be set up postsurgically as soon as possible and prior to the patient leaving the post-anesthesia care unit (PACU) or immediately upon transfer to the floor if the stay in the PACU is less than 1 hour.

DRUG

EXPAREL (bupivacaine liposome injectable suspension)

"Patients in this group will receive 266 mg EXPAREL diluted with preservative free 0.9% normal saline to a total volume of 30 cc and administered via wound infiltration prior to wound closure. When not contraindicated, 30 mg IV ketorolac, a non-steroidal anti-inflammatory drug (NSAID), may be substituted per the site's standard of care.~All patients will be offered rescue analgesia, as needed."

Trial Locations (1)

33136

University of Miami, Dept of Anesthesiology, Miami

Sponsors
All Listed Sponsors
collaborator

Registrat-Mapi

OTHER

lead

Pacira Pharmaceuticals, Inc

INDUSTRY

NCT01507233 - A Health Economic Trial in Adult Patients Undergoing Open Colectomy MA402S23B302 | Biotech Hunter | Biotech Hunter